Logo

ATMCR

AlphaTime Acquisition Corp Right

ATMCR

AlphaTime Acquisition Corp Right • NASDAQ
$0.20 ▲ 0.00% (+0.00)
Market Cap $701870
52w High $0.20
52w Low $0.19
Dividend Yield 0%
P/E 0
Volume 277
Outstanding Shares 3.47M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $0 ▼ $165.713K ▲ 0% $-0.01 ▲ $0 ▲
Q2-2025 $0 $290.004K ▲ $-127.315K ▼ 0% $-0.037 ▼ $-290.004K ▼
Q1-2025 $0 ▼ $183.402K ▼ $117.969K ▼ 0% ▼ $0.017 ▼ $143.864K ▼
Q4-2024 $1.831M ▲ $420.613K ▲ $266.589K ▼ 14.56% ▲ $0.039 ▼ $2.743M ▲
Q3-2024 $0 $280.163K $404.367K 0% $0.059 $-280K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.281K ▼ $16.051M ▲ $6.384M ▲ $-6.357M ▼
Q2-2025 $1.329K ▼ $15.861M ▲ $6.36M ▲ $9.501M ▼
Q1-2025 $1.377K ▼ $15.673M ▲ $6.045M ▲ $9.628M ▲
Q4-2024 $1.425K ▼ $15.257M ▼ $5.747M ▲ $9.511M ▲
Q3-2024 $1.473K $53.381M $5.284M $-5.251M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $132.658K ▲ $-5.067K ▼ $38.747M ▲ $-38.742M ▼ $-48 ▲ $-5.067K ▼
Q2-2025 $-94.26K ▼ $104.931K ▲ $-38.847M ▼ $38.742M ▲ $-96 ▼ $104.931K ▲
Q1-2025 $117.969K ▲ $54.931K ▲ $-54.979K ▼ $0 ▲ $-48 $54.931K ▲
Q4-2024 $84.914K ▼ $-48 ▼ $38.742M ▲ $-38.742M ▼ $-48 ▼ $-48 ▼
Q3-2024 $404.367K $5.625K $-5.189M $5.184M $0 $5.623K

Five-Year Company Overview

Income Statement

Income Statement ATMCR’s income statement is largely a formality at this stage. As a SPAC right, it does not yet sit on top of an operating business with real revenue or margins. The tiny positive earnings per right mainly reflect financial accounting around the SPAC structure, not a functioning company that is selling products or services. In practical terms, the current income statement tells you almost nothing about the earning power of the future combined company; that will depend on HCYC’s results once the merger closes and they begin reporting as a single entity.

Balance Sheet

Balance Sheet The balance sheet for ATMCR is minimal and typical for a SPAC-related instrument. There is a small base of assets and equity, and essentially no operating debt or tangible business assets. The economic reality is that the value of the right is tied to the future combined company, not the current shell balance sheet. For now, the balance sheet mostly reflects a financing vehicle waiting to complete a transaction rather than a business with property, equipment, or large working capital needs.

Cash Flow

Cash Flow Reported cash flows are essentially flat, again consistent with a SPAC right that has no standalone operations. There is no meaningful operating cash generation, no capital spending, and no traditional free cash flow story to analyze. The relevant cash flow questions sit on the HCYC side: their ability, after the merger, to turn brokerage and advisory activity into steady cash earnings, and to do so without consuming heavy amounts of capital to grow.

Competitive Edge

Competitive Edge ATMCR itself has no competitive position; it is simply a financing mechanism. The future story rests on HCYC. HCYC appears to occupy a specialized niche: serving business owners, executives, and wealthy individuals in Hong Kong, mainland China, and parts of Southeast Asia. Its strengths seem to be long-standing relationships with major global insurers, a track record of over a decade, and a base in a major financial center. These factors can create switching costs and client loyalty. On the other hand, the insurance brokerage market is crowded, regulatory expectations are strict, and technology-driven competitors are rising. The note around AXA Macau and authorization concerns also highlights that regulatory and reputational risk are real competitive threats that could weaken their position if not managed carefully.

Innovation and R&D

Innovation and R&D Neither ATMCR nor HCYC is a classic high‑R&D, tech‑heavy story. The innovation is more about how HCYC packages insurance, consulting, and asset management into an integrated offering for wealthy clients, and how it uses partner insurers’ technology rather than building everything in‑house. This keeps capital needs lower but can also limit differentiation if rivals gain access to similar tools. The loosely defined “insurance technology innovation” segment is a watch point: if HCYC turns this into concrete platforms, data tools, or digital client experiences, it could deepen its moat; if it remains vague, the business may look more like a traditional broker with only modest tech advantages.

Summary

ATMCR, as a SPAC right, currently represents a claim on a future equity interest rather than a conventional operating company. Its historical financials are thin and mainly mechanical. The real substance sits with HCYC, the Hong Kong insurance broker it plans to merge with. HCYC brings a focused niche in high‑net‑worth and cross‑border clients, strong relationships with large insurers, and a base in a growing regional market, but it also faces regulatory scrutiny, intense competition, and the need to prove that its technology and asset‑management ambitions are more than marketing language. Overall, the situation is highly dependent on successful completion of the merger and on HCYC’s execution in the first few years as a public company, when strategy, governance, and regulatory track record will come under closer scrutiny.